Sandrine Flory
Director/Board Member presso TRANSGENE
Profilo
Sandrine Flory is currently a Director at Transgene SA, TSGH SAS, GeNeuro SA (Switzerland), and Institut Mérieux SA. She previously worked as the Chief Financial Officer-EMEA Division at bioMérieux SA. Ms. Flory holds a graduate degree from Universite Lumiere Lyon 2.
Posizioni attive di Sandrine Flory
Società | Posizione | Inizio |
---|---|---|
TRANSGENE | Director/Board Member | 01/01/2021 |
GENEURO SA | Director/Board Member | 18/03/2024 |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Director of Finance/CFO | 01/01/2020 |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Director/Board Member | 01/01/2002 |
Precedenti posizioni note di Sandrine Flory
Società | Posizione | Fine |
---|---|---|
BIOMÉRIEUX | Corporate Officer/Principal | 01/01/2020 |
Formazione di Sandrine Flory
Universite Lumiere Lyon 2 | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
GENEURO SA | Health Technology |
Aziende private | 2 |
---|---|
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
- Borsa valori
- Insiders
- Sandrine Flory